ClinicalTrials.Veeva

Find clinical trials for Non-Hodgkin Lymphoma in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Lymphoma
B-Cell Lymphoma
Diffuse Large B-Cell Lymphoma
Leukemia
B-Cell Chronic Lymphocytic Leukemia
Lymphoid Leukemia
Mantle-Cell Lymphoma

Non-Hodgkin Lymphoma trials near Salt Lake City, UT, USA:

Copanlisib and Rituximab in Relapsed Indolent B-cell Non-Hodgkin's Lymphoma (iNHL) (CHRONOS-3)

The purpose of this study was to evaluate whether copanlisib in combination with rituximab is superior to placebo in combination with rituximab in pr...

Active, not recruiting
Lymphoma,Non-Hodgkin
Drug: Rituximab
Drug: Placebo

Phase 3

Bayer
Bayer

Salt Lake City, Utah, United States and 188 other locations

Part 1: To characterize the safety profile of acalabrutinib alone or in combination with rituximab in subjects with R/R FL.Part 2: To characterize th...

Active, not recruiting
Non Hodgkin Lymphoma
Drug: acalabrutinib
Drug: rituximab (IV)

Phase 1, Phase 2

Acerta Pharma
Acerta Pharma

Salt Lake City, Utah, United States and 31 other locations

CB010A is a study evaluating safety, emerging efficacy, pharmacokinetics and immunogenicity of CB-010 in adults with relapsed/refractory B cell non...

Enrolling
Refractory B-Cell Non-Hodgkin Lymphoma
B Cell Lymphoma
Drug: Cyclophosphamide
Genetic: CB-010

Phase 1

Caribou Biosciences

Salt Lake City, Utah, United States and 29 other locations

(CAR) T cells, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.The study will consist of 2 parts: dose...

Active, not recruiting
Agressive Lymphoma
Diffuse-large B-cell Lymphoma (DLBCL)
Biological: CC-97540

Phase 1

Juno Therapeutics

Salt Lake City, Utah, United States and 13 other locations

clinical trial will enroll patients with relapsed/refractory non-Hodgkin lymphoma of B-cell origin and is conducted in two...

Enrolling
Non Hodgkin Lymphoma
Drug: Rituximab
Drug: Cyclophosphamide

Phase 1, Phase 2

Artiva Biotherapeutics

Salt Lake City, Utah, United States and 20 other locations

This is a Phase 1/2, multi-center, open-label study evaluating the safety and efficacy of IMPT-314, a bispecific chimeric antigen receptor (CAR) targ...

Enrolling
Relapsed Non-Hodgkin Lymphoma
Refractory Non-Hodgkin Lymphoma
Drug: IMPT-314

Phase 1, Phase 2

ImmPACT Bio

Salt Lake City, Utah, United States and 19 other locations

This is a Phase I/II, multicenter, open-label, dose-escalation study designed to evaluate the efficacy, safety, tolerability and pharmacokinetics (PK...

Enrolling
Non-Hodgkin's Lymphoma
Drug: Glofitamab
Drug: Obinutuzumab

Phase 1, Phase 2

Roche
Roche

Salt Lake City, Utah, United States and 40 other locations

in treating patients with chronic lymphocytic leukemia or aggressive non-Hodgkin lymphoma that has returned after a period...

Active, not recruiting
Recurrent Small Lymphocytic Lymphoma
Recurrent Mantle Cell Lymphoma
Other: Pharmacological Study
Drug: Selinexor

Phase 1

Jennifer Woyach

Salt Lake City, Utah, United States and 1 other location

if it works to treat the diseases under study. The diseases under study will be Renal Cell Carcinoma (RCC),Nasopharyngeal Carcinoma (NPC) and Non...

Enrolling
Non Hodgkin Lymphoma
Nasopharyngeal Carcinoma
Drug: PRO1160

Phase 1, Phase 2

ProfoundBio

West Valley City, Utah, United States of America and 17 other locations

Follicular lymphoma (FL), marginal zone lymphoma (MZL), and mantle cell lymphoma (MCL) are distinct histologic types of B-...

Active, not recruiting
Lymphoma, Non-Hodgkin
Drug: Rituximab
Drug: Lenalidomide

Phase 3

Celgene
Celgene

Salt Lake City, Utah, United States and 125 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems